Rebif and Muscle spasticity - from FDA reports


Summary

Muscle spasticity is found among people who take Rebif, especially for people who are female, 50-59 old , have been taking the drug for 2 - 5 years, also take medication Baclofen, and have Depression. This review analyzes which people have Muscle spasticity with Rebif. It is created by eHealthMe based on reports of 47,485 people who have side effects when taking Rebif from FDA , and is updated regularly.

What to expect?

If you take Rebif and have Muscle spasticity, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Rebif and have Muscle spasticity

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Aug, 23, 2017

47,485 people reported to have side effects when taking Rebif.
Among them, 249 people (0.52%) have Muscle spasticity


Number of reports submitted per year:

Could Rebif cause Muscle spasticity?

Time on Rebif when people have Muscle spasticity *:

  • < 1 month: 11.32 %
  • 1 - 6 months: 13.21 %
  • 6 - 12 months: 7.55 %
  • 1 - 2 years: 11.32 %
  • 2 - 5 years: 39.62 %
  • 5 - 10 years: 7.55 %
  • 10+ years: 9.43 %

Gender of people who have Muscle spasticity when taking Rebif *:

  • female: 77.11 %
  • male: 22.89 %

Age of people who have Muscle spasticity when taking Rebif *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 1.14 %
  • 20-29: 7.95 %
  • 30-39: 22.73 %
  • 40-49: 23.3 %
  • 50-59: 23.86 %
  • 60+: 21.02 %

Top conditions involved for these people *:

  • Depression (14 people, 5.62%)
  • Secondary Progressive Multiple Sclerosis (8 people, 3.21%)
  • Pain (7 people, 2.81%)
  • Gait Disturbance (7 people, 2.81%)
  • Diabetes (4 people, 1.61%)

Top co-used drugs for these people *:

  • Baclofen (37 people, 14.86%)
  • Ibuprofen (19 people, 7.63%)
  • Ampyra (13 people, 5.22%)
  • Tylenol (12 people, 4.82%)
  • Fish Oil (10 people, 4.02%)

Top other side effects for these people *:

  • Weakness (43 people, 17.27%)
  • Fatigue (35 people, 14.06%)
  • Gait Disturbance (33 people, 13.25%)
  • Hypoaesthesia (31 people, 12.45%)
  • Injection Site Pain (29 people, 11.65%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Muscle spasticity when taking Rebif?

Expand the study to include all drugs with the same ingredients

Muscle spasticity and drugs with ingredients of interferon beta-1a.

Expand the study to include reports from both FDA and eHealthMe

Muscle spasticity and Rebif from FDA and eHealthMe reports

Rebif

Rebif has active ingredients of interferon beta-1a. It is often used in multiple sclerosis. (latest outcomes from Rebif 47,755 users)

Muscle spasticity

Muscle spasticity (tight or stiff muscles and an inability to control those muscles) has been reported by people with multiple sclerosis, muscle spasticity, pain, depression, high blood pressure (latest reports from 24,674 Muscle spasticity patients).

Browse all side effects of Rebif

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Muscle spasticity

Muscle spasticity

Could your condition cause Muscle spasticity

Muscle spasticity

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Rebif and have Muscle spasticity.

Questions to the study

More questions >

User reviews to the study

More reviews >